biomArker-guided Duration of Antibiotic treatment in hospitalised Patients with suspecTed Sepsis (ADAPT-Sepsis): A protocol for a multicentre randomised controlled trial
Paul Dark(University Hospital of Wales), Ranjit Lall(Coventry (United Kingdom)), Timothy Walsh(Duke University), Dipesh Mistry(University of Warwick), Matt Stevenson(DuPont (United States)), Kay Marshall, Anthony Gordon(University of Copenhagen), Peter Wilson(University of Sheffield), Paul Mouncey(Intensive Care National Audit & Research Centre), Jonathan B. Clayton(University of Nebraska–Lincoln), Keith A. Young, Gavin D. Perkins(University Hospitals Coventry and Warwickshire NHS Trust), Nicola McGowan(University of Warwick), Nazir Lone(University of Edinburgh), Tim Felton, Scott Regan(Cancer Research UK Clinical Trials Unit), Simon Gates(Oxford Brookes University), Mervyn Singer(Bury College), Anower M. Hossain(University of Warwick), Ronan McMullan(Belfast Health and Social Care Trust)
Cited by 14
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Interventions for preventing falls in older people living in the community
|Cochrane Database of Systematic Reviews|2012|3.9k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Trial of Early, Goal-Directed Resuscitation for Septic Shock
|New England Journal of Medicine|2015|1.6k